SCOPUS 정보 검색 플랫폼

Journal of the National Cancer Institute

Volumn 92, Issue 21, 2000, Pages 1704-1706

Role of perspective and other uncertainties in cost-effectiveness assessments in advanced prostate cancer

(2) Hillner, Bruce E a,b Roberts, John D a

a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE (United States)

b VIRGINIA COMMONWEALTH UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

CANCER HORMONE THERAPY; CASTRATION; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; EDITORIAL; HEALTH CARE COST; HUMAN; MALE; MEDICARE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE;

EID: 0034329588 PISSN: 00278874 EISSN: None Source Type: Journal
DOI: 10.1093/jnci/92.21.1704 Document Type: Editorial

Times cited : (4)

References (22)

1
- 84897363178
- Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer
- No. 4, January
- (1999) Summary, evidence report/technology assessment

2
- 0034329574
- Cost-effectiveness of androgen suppression therapies in advanced prostate cancer
- (2000) J Natl Cancer Inst , vol.92 , pp. 1731-1739
- Bayoumi, A.M.¹ Brown, A.D.² Garber, A.M.³

3
- 0028074701
- The journal's policy on cost-effectiveness analyses
- (1994) N Engl J Med , vol.331 , pp. 669-670
- Kassirer, J.P.¹ Angell, M.²

4
- 0032724035
- Evaluation of conflict of interest in economic analyses of new drugs used in oncology
- (1999) JAMA , vol.282 , pp. 1453-1457
- Friedberg, M.¹ Saffran, B.² Stinson, T.J.³ Nelson, W.⁴ Bennett, C.L.⁵

5
- 0029794708
- Recommendations of the panel on cost-effectiveness in health and medicine
- (1996) JAMA , vol.276 , pp. 1253-1258
- Weinstein, M.C.¹ Siegel, J.E.² Gold, M.R.³ Kamlet, M.S.⁴ Russell, L.B.⁵

6
- 0034603826
- Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis
- (2000) Ann Intern Med , vol.132 , pp. 566-577
- Seidenfeld, J.¹ Samson, D.J.² Hasselblad, V.³ Aronson, N.⁴ Albertsen, P.C.⁵ Bennett, C.L.⁶

7
- 0033905178
- The cost value of medical versus surgical hormonal therapy for metastatic prostate cancer
- (2000) J Urol , Issue.3 PART 1 , pp. 735-737
- Chon, J.K.¹ Jacobs, S.C.² Naslund, M.J.³

8
- 0027417437
- The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
- (1993) J Natl Cancer Inst , vol.85 , pp. 365-376
- Aaronson, N.K.¹ Ahmedzai, S.² Bergman, B.³ Bullinger, M.⁴ Cull, A.⁵ Duez, N.J.⁶

9
- 0031934333
- Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer
- (1998) J Clin Oncol , vol.16 , pp. 1022-1029
- Hayman, J.A.¹ Hillner, B.E.² Harris, J.R.³ Weeks, J.C.⁴

10
- 0029867410
- Cost-effective models for flutamide for prostate carcinoma patients: Are they helpful to policy makers?
- (1996) Cancer , vol.77 , pp. 1854-1861
- Bennett, C.L.¹ Matchar, D.² McCrory, D.³ McLeod, D.G.⁴ Crawford, E.D.⁵ Hillner, B.E.⁶

11
- 0028826444
- Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer
- (1995) Urology , vol.45 , pp. 633-640
- Hillner, B.E.¹ McLeod, D.G.² Crawford, E.D.³ Bennett, C.L.⁴

12
- 0034728828
- Maximum androgen blockade in advanced prostate cancer: An overview of the randomised trials
- (2000) Lancet , vol.355 , pp. 1491-1498

13
- 0029103141
- Maximum androgen blockade in advanced prostate cancer: An overview of 22 randomised trials with 3283 deaths in 5710 patients
- (1995) Lancet , vol.346 , pp. 265-269

14
- 0023726635
- Hormone therapy for prostate cancer: Results of the Veterans Administration Cooperative Urological Research Group Studies
- (1988) NCI Monogr , vol.7 , pp. 165-170
- Byar, D.P.¹ Corie, D.K.²

15
- 0015749215
- Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate
- (1973) Cancer , vol.32 , pp. 1126-1130
- Byar, D.P.¹

16
- 0031403675
- Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial
- (1997) Br J Urol , vol.79 , pp. 235-246

17
- 0033540004
- Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
- (1999) N Engl J Med , vol.341 , pp. 1781-1788
- Messing, E.M.¹ Manola, J.² Sarosdy, M.³ Wilding, G.⁴ Crawford, E.D.⁵ Trump, D.⁶

18
- 0034114889
- Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy
- (2000) J Urol , vol.163 , pp. 1743-1746
- Herr, H.W.¹ O'Sullivan, M.²

19
- 0034126060
- Fatigue in patients with prostate cancer receiving hormone therapy
- (2000) Eur J Cancer , vol.36 , pp. 1134-1141
- Stone, P.¹ Hardy, J.² Huddart, R.³ A'Hern, R.⁴ Richards, M.⁵

20
- 0031012642
- Osteoporosis after orchiectomy for prostate cancer
- (1997) J Urol , vol.157 , pp. 439-444
- Daniell, H.W.¹

21
- 0007450433
- Prostate Cancer Treatment Trial. Phase III. Open. Recurrent Disease

22
- 0007377648
- Closed 4/6/1998. Accessed September 13, 2000
- Randomized phase III trial of immediate versus deferred hormonal therapy in patients with elevated PSA after definitive treatment for localised prostate cancer

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.